Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
15002134094 |
Email: |
marketing@targetmol.cn |
Products Intro: |
Product Name:MS-073 CAS:129716-45-6 Package:50mg/RMB 13800;25mg/RMB 10600;100mg/RMB 17500
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:MS-073 CAS:129716-45-6 Purity:98%
|
MS 073 manufacturers
- MS-073
-
- $1980.00 / 50mg
-
2024-10-28
- CAS:129716-45-6
- Min. Order:
- Purity:
- Supply Ability: 10g
|
Product Name: | MS 073 | Synonyms: | MS 073;1-(Quinolin-5-yloxy)-3-[4-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten)-5-yl]piperazin-1-yl]-2-propanol;CP-162398;1-Piperazineethanol, 4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-α-[(5-quinolinyloxy)methyl]- | CAS: | 129716-45-6 | MF: | C31H33N3O2 | MW: | 479.61 | EINECS: | | Product Categories: | | Mol File: | 129716-45-6.mol | |
| MS 073 Chemical Properties |
| MS 073 Usage And Synthesis |
Description | MS-073, also known as CP-162398, is a P-glycoprotein inhibitor (P-gp). MS-073 was compared with verapamil with regard to its ability to overcome MDR in vitro and in vivo. MS-073 at 0.1 microM almost completely reversed in vitro resistance to vincristine (VCR) in VCR-resistant P388 cells. MS-073 also reversed in vitro VCR, adriamycin (ADM), etoposide, and actinomycin D resistance in ADM-resistant human myelogenous leukemia K562 (K562/ADM) cells, MS-073 reverses MDR by competitively inhibiting drug binding to P-glycoprotein. |
| MS 073 Preparation Products And Raw materials |
|